Mesoblast Limited (MESO) has a market capitalization of $1.88B and trades at $14.61. The 52-week range is 9.61-21.5.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -17.4, Earnings Per Share (EPS) of $-0.84, annual revenue of $17.2M.
The stock has a beta of 0.82, operates in the Healthcare sector.
